-
-
-
-
-
-
-
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
-
-
-
-
-
-
-
ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
-
-
-
-
-
-
-
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
-
-
-
-
-
-
-
ReShape Lifesciences™ Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
ReShape Lifesciences™ Appoints Al Diaz as Vice President of Operations and Research and Development
-
-
-
-
-
-
-
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger
-
1,154,895 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

